These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 21514878)

  • 1. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma.
    Kokko LL; Hurme S; Maula SM; Alanen K; Grénman R; Kinnunen I; Ventelä S
    Oral Oncol; 2011 Jun; 47(6):510-6. PubMed ID: 21514878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
    Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
    In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9.
    Sterz CM; Kulle C; Dakic B; Makarova G; Böttcher MC; Bette M; Werner JA; Mandic R
    Oral Oncol; 2010 Feb; 46(2):116-22. PubMed ID: 20036607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
    Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
    J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region.
    Maula SM; Luukkaa M; Grénman R; Jackson D; Jalkanen S; Ristamäki R
    Cancer Res; 2003 Apr; 63(8):1920-6. PubMed ID: 12702584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
    Lim YC; Kang HJ; Moon JH
    Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
    Cabanillas R; Rodrigo JP; Astudillo A; Domínguez F; Suárez C; Chiara MD
    Cancer; 2007 May; 109(9):1791-8. PubMed ID: 17380529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD44 is a potential marker for the early detection of head and neck cancer.
    Franzmann EJ; Reategui EP; Pedroso F; Pernas FG; Karakullukcu BM; Carraway KL; Hamilton K; Singal R; Goodwin WJ
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1348-55. PubMed ID: 17627000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis.
    Chow TL; Lee DT; Choi CY; Chan TT; Lam SH
    Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):882-5. PubMed ID: 19770420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-32 expression is associated with a poorer prognosis in head and neck squamous cell carcinoma.
    Guenin S; Mouallif M; Hubert P; Jacobs N; Krusy N; Duray A; Ennaji MM; Saussez S; Delvenne P
    Mol Carcinog; 2014 Aug; 53(8):667-73. PubMed ID: 23359495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of CD44 variant 9-expressing cancer stem cells might attenuate the efficacy of chemoradioselection and Worsens the prognosis of patients with advanced head and neck cancer.
    Aso T; Matsuo M; Kiyohara H; Taguchi K; Rikimaru F; Shimokawa M; Segawa Y; Higaki Y; Umeno H; Nakashima T; Masuda M
    PLoS One; 2015; 10(3):e0116596. PubMed ID: 25751671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer.
    Imai R; Takenaka Y; Yasui T; Nakahara S; Yamamoto Y; Hanamoto A; Takemoto N; Fukusumi T; Cho H; Yamamoto M; Inohara H
    Acta Otolaryngol; 2015 Mar; 135(3):295-301. PubMed ID: 25622661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heavy alcohol drinking downregulates ALDH2 gene expression but heavy smoking up-regulates SOD2 gene expression in head and neck squamous cell carcinoma.
    Lee DJ; Lee HM; Kim JH; Park IS; Rho YS
    World J Surg Oncol; 2017 Aug; 15(1):163. PubMed ID: 28841898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.
    Chen J; Zhou J; Lu J; Xiong H; Shi X; Gong L
    BMC Cancer; 2014 Jan; 14():15. PubMed ID: 24410905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
    Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
    J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EB-D fibronectin expression in squamous cell carcinoma of the head and neck.
    Mhawech P; Dulguerov P; Assaly M; Ares C; Allal AS
    Oral Oncol; 2005 Jan; 41(1):82-8. PubMed ID: 15598590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.
    Geomela PA; Kontos CK; Yiotakis I; Scorilas A
    J Oral Pathol Med; 2013 Feb; 42(2):154-61. PubMed ID: 22747515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
    Masuda M; Suzui M; Yasumatu R; Nakashima T; Kuratomi Y; Azuma K; Tomita K; Komiyama S; Weinstein IB
    Cancer Res; 2002 Jun; 62(12):3351-5. PubMed ID: 12067972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein.
    Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
    Clin Cancer Res; 2005 May; 11(9):3257-64. PubMed ID: 15867221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.